A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma

BACKGROUND: Unresectable biliary tract carcinoma is known to demonstrate a poor prognosis. We conducted a single arm phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) for advanced biliary tract malignancies basically on an outpa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kazuma, Tsuji, Akihito, Morita, Sojiro, Horimi, Tadashi, Shirasaka, Tetsuhiko, Kanematsu, Takashi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483897/
https://www.ncbi.nlm.nih.gov/pubmed/16677397
http://dx.doi.org/10.1186/1471-2407-6-121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483897/
https://www.ncbi.nlm.nih.gov/pubmed/16677397
http://dx.doi.org/10.1186/1471-2407-6-121

Ejemplares similares